Editorial: Developing personalized treatment in neurodegenerative disorders: role of genomics and novel technologies in identifying actionable targets and developing interventions in rare-diseases.

导出 OA

翻译打印收藏纠错

作者： Anja,Kovanda ^[1] ; Sabina,Vatovec ^[2] ; Valentino,Rački ^[3]

作者单位： Clinical Institute of Genomic Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia. ^[1] Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia. ^[2] Novartis, Ljubljana, Slovenia. ^[3] Faculty of Medicine, University of Rijeka, Rijeka, Croatia. ^[4]

关键词 actionable targets deep brain stimulation (DBS)exome sequencing (ES)genomics glycomics mass spectrometry neurodegenerative diseases personalized treatment whole genome sequencing (WGS)

DOI 10.3389/fnins.2024.1403015

PMID 38655105

发布时间 2024-04-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in neuroscience

2024年18卷

1403015页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Editorial: Developing personalized treatment in neurodegenerative disorders: role of genomics and novel technologies in identifying actionable targets and developing interventions in rare-diseases.

Frontiers in neuroscience

相似文献

Frontiers in neuroscience

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Editorial: Developing personalized treatment in neurodegenerative disorders: role of genomics and novel technologies in identifying actionable targets and developing interventions in rare-diseases.

Frontiers in neuroscience

相似文献

Frontiers in neuroscience

相关期刊

检索历史清除